EndoBarrier, a gastrointestinal liner developed by GI Dynamics, has shown promise in the treatment of obesity in a trial. The device is a non-surgical therapy to treat type 2 diabetes and obesity. It is approved for use in Europe and in advanced clinical development in the US. EndoBarrier is ...
Please Login to read the full article.
